Published in J Psychoactive Drugs on December 31, 2013
Lifetime suicide attempt history, quality of life, and objective functioning among HIV/AIDS patients with alcohol and illicit substance use disorders. Int J STD AIDS (2015) 0.77
Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: the DHIVA study. AIDS Care (2015) 0.77
Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clin Psychol Rev (2016) 0.75
Longitudinal changes in personal wellbeing in a cohort of people who inject drugs. PLoS One (2017) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol (1988) 26.07
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev (2005) 8.14
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22
Role of depression, stress, and trauma in HIV disease progression. Psychosom Med (2008) 3.65
Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry (2008) 3.64
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res (1997) 3.16
Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res (1999) 3.00
Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res (1997) 2.75
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med (2000) 2.31
Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry (2002) 2.26
Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21
A review of barriers and facilitators of HIV treatment among injection drug users. AIDS (2008) 2.21
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry (2000) 1.90
Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS Behav (2005) 1.67
Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy (2009) 1.63
Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res (2005) 1.60
Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med (2001) 1.57
Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med (1997) 1.52
Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res (2004) 1.46
WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry (1994) 1.46
Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am (1994) 1.43
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. AIDS Care (2007) 1.42
Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res (2005) 1.39
Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res (2002) 1.39
Traumatic stress in HIV-infected women. AIDS Educ Prev (1999) 1.38
A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care STDS (2006) 1.38
The impact of HIV/AIDS on the quality of life: a cross sectional study in north India. Indian J Med Sci (2006) 1.36
The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse (2010) 1.18
Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS (2008) 1.17
Posttraumatic stress disorder in response to HIV infection. Gen Hosp Psychiatry (1998) 1.16
Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry (2003) 1.14
Panic disorder and pain in a national sample of persons living with HIV. Pain (2004) 1.13
Functional impairment and health care utilization among HIV-infected men who have sex with men: the relationship with depression and post-traumatic stress. J Behav Med (2009) 1.12
Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry (1997) 1.10
The impact of PTSD on pain experience in persons with HIV/AIDS. Pain (2002) 0.96
Quality of life among urban Canadian HIV/AIDS clinic outpatients. Int J STD AIDS (2001) 0.94
Human immunodeficiency virus (HIV) infection and quality of life: the potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med (1997) 0.86
Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res (1997) 0.85
Measurement of quality of life of HIV individuals: Perspectives & future directions. Indian J Med Res (2005) 0.83
Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China. Am J Drug Alcohol Abuse (2010) 0.82
Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples. Ann Pharmacother (2009) 0.76